skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
 Pathways Across the Valley of Death: Novel Intellectual... Preview this item
ClosePreview this item
Checking...

Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery

Author: Rai, Arti K.; Reichman, Jerome H.; Uhlir, Paul F.; Crossman, Colin
Publisher: Duke University School of Law 2008-01-01T08:00:00Z
Edition/Format:   Downloadable article : English
Publication:Faculty Scholarship
Summary:
Drug discovery is stagnating. Government agencies, industry analysts, and industry scientists have all noted that, despite significant increases in pharmaceutical R&D funding, the production of fundamentally new drugs - particularly drugs that work on new biological pathways and proteins - remains disappointingly low. To some extent, pharmaceutical firms are already embracing the prescription of new, more  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: text
Material Type: Internet resource
Document Type: Internet Resource, Article
All Authors / Contributors: Rai, Arti K.; Reichman, Jerome H.; Uhlir, Paul F.; Crossman, Colin
OCLC Number: 809548427
Language Note: English
Notes: application/pdf

Abstract:

Drug discovery is stagnating. Government agencies, industry analysts, and industry scientists have all noted that, despite significant increases in pharmaceutical R&D funding, the production of fundamentally new drugs - particularly drugs that work on new biological pathways and proteins - remains disappointingly low. To some extent, pharmaceutical firms are already embracing the prescription of new, more collaborative R&D organizational models suggested by industry analysts. In this Article, we build on collaborative strategies that firms are already employing by proposing a novel public-private collaboration that would help move upstream academic research across the valley of death that separates upstream research from downstream drug candidates. By exchanging trade secrecy for contract-based collaboration, our proposal would both protect intellectual property rights and enable many more researchers to search for potential drug candidates.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/809548427<\/a>> # Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Article<\/a>, schema:MediaObject<\/a>, schema:CreativeWork<\/a>, pto:Web_document<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"809548427<\/span>\" ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/antitrust_and_trade_regulation<\/a>> ; # Antitrust and Trade Regulation<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/innovation<\/a>> ; # innovation<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/medical_jurisprudence<\/a>> ; # Medical Jurisprudence<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/law<\/a>> ; # Law<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/pharmaceutical_patents<\/a>> ; # pharmaceutical patents<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/small_molecule_drugs<\/a>> ; # small molecule drugs<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/intellectual_property<\/a>> ; # Intellectual Property<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/crossman_colin<\/a>> ; # Crossman, Colin<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/rai_arti_k<\/a>> ; # Rai, Arti K.<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/uhlir_paul_f<\/a>> ; # Uhlir, Paul F.<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/reichman_jerome_h<\/a>> ; # Reichman, Jerome H.<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2008<\/span>\" ;\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2008\/01\/01T08:00:00Z<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"Drug discovery is stagnating. Government agencies, industry analysts, and industry scientists have all noted that, despite significant increases in pharmaceutical R&D funding, the production of fundamentally new drugs - particularly drugs that work on new biological pathways and proteins - remains disappointingly low. To some extent, pharmaceutical firms are already embracing the prescription of new, more collaborative R&D organizational models suggested by industry analysts. In this Article, we build on collaborative strategies that firms are already employing by proposing a novel public-private collaboration that would help move upstream academic research across the valley of death that separates upstream research from downstream drug candidates. By exchanging trade secrecy for contract-based collaboration, our proposal would both protect intellectual property rights and enable many more researchers to search for potential drug candidates.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/792280558<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"text<\/span>\" ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery<\/span>\" ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"809548427<\/span>\" ;\u00A0\u00A0\u00A0\nschema:publication<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/809548427#PublicationEvent\/duke_university_school_of_law2008_01_01t08_00_00z<\/a>> ;\u00A0\u00A0\u00A0\nschema:publisher<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/duke_university_school_of_law<\/a>> ; # Duke University School of Law<\/span>\n\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/scholarship.law.duke.edu\/faculty_scholarship\/1630<\/a>> ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/scholarship.law.duke.edu\/cgi\/viewcontent.cgi?article=2329&context=faculty_scholarship<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/809548427<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/crossman_colin<\/a>> # Crossman, Colin<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Crossman, Colin<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/duke_university_school_of_law<\/a>> # Duke University School of Law<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Duke University School of Law<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/rai_arti_k<\/a>> # Rai, Arti K.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Rai, Arti K.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/reichman_jerome_h<\/a>> # Reichman, Jerome H.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Reichman, Jerome H.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Agent\/uhlir_paul_f<\/a>> # Uhlir, Paul F.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Uhlir, Paul F.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/antitrust_and_trade_regulation<\/a>> # Antitrust and Trade Regulation<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Antitrust and Trade Regulation<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/innovation<\/a>> # innovation<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"innovation<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/intellectual_property<\/a>> # Intellectual Property<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Intellectual Property<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/law<\/a>> # Law<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Law<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/medical_jurisprudence<\/a>> # Medical Jurisprudence<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Medical Jurisprudence<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/pharmaceutical_patents<\/a>> # pharmaceutical patents<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"pharmaceutical patents<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/792280558#Thing\/small_molecule_drugs<\/a>> # small molecule drugs<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"small molecule drugs<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/809548427<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/809548427<\/a>> ; # Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2019-02-09<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat\/DigitalCollectionGateway<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n